Androgen levels in the third trimester of pregnancy in patients with preeclampsia.

[1]  R. Hoover,et al.  Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. , 2003, International journal of epidemiology.

[2]  M. Waterman,et al.  Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  F. Lyall.  Development of the utero‐placental circulation: The role of carbon monoxide and nitric oxide in trophoblast invasion and spiral artery transformation , 2003, Microscopy research and technique.

[4]  R. Magness,et al.  Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  M. Wolf,et al.  Insulin Resistance But Not Inflammation Is Associated With Gestational Hypertension , 2002, Hypertension.

[6]  N. Page.  The endocrinology of pre‐eclampsia , 2002, Clinical endocrinology.

[7]  U. Meinhardt,et al.  The Essential Role of the Aromatase/P450arom , 2002, Seminars in reproductive medicine.

[8]  S. Yagel,et al.  Regulation of trophoblast invasion: from normal implantation to pre-eclampsia , 2002, Molecular and Cellular Endocrinology.

[9]  L. Kragie.  AROMATASE IN PRIMATE PREGNANCY: A REVIEW , 2002, Endocrine research.

[10]  M. Başbuğ,et al.  Androgen levels of preeclamptic patients in the third trimester of pregnancy and six weeks after delivery , 2001, Acta obstetricia et gynecologica Scandinavica.

[11]  I. Buxton,et al.  Hypertension as a Complication of Topical Testosterone Therapy , 2001, The Annals of pharmacotherapy.

[12]  J. Granger,et al.  Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. , 2001, Hypertension.

[13]  D. Seachrist,et al.  Testosterone increases blood pressure and cardiovascular and renal pathology in spontaneously hypertensive rats. , 2000, Blood pressure.

[14]  J F Reckelhoff,et al.  Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. , 2000, Hypertension.

[15]  C. Mantzoros,et al.  Androgens in preeclampsia. , 1999, American journal of obstetrics and gynecology.

[16]  H. Laivuori,et al.  Evidence of high circulating testosterone in women with prior preeclampsia. , 1998, The Journal of clinical endocrinology and metabolism.

[17]  B. Sibai,et al.  Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. , 1992, American journal of obstetrics and gynecology.

[18]  H. Gjønnæss.  The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: the influence of body-weight. , 1989 .

[19]  J. D. Martin,et al.  Metabolism of androstenedione by placental microsomes in pregnancy hypertension. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[20]  T. Onaya,et al.  The effects of sex hormones on the synthesis of prostacyclin (PGI2) by vascular tissues. , 1989, Prostaglandins.

[21]  P. Croft,et al.  Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. , 1989, BMJ.

[22]  B. Sibai,et al.  Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. , 1986, American journal of obstetrics and gynecology.

[23]  Y. Diamant,et al.  High incidence of preeclamptic toxemia in patients with polycystic ovarian disease. , 1982, European journal of obstetrics, gynecology, and reproductive biology.

[24]  R. Elashoff,et al.  Interrelationships of circulating maternal steroid concentrations in third trimester pregnancies. II. C18 and C19 steroids: estradiol, estriol, dehydroepiandrosterone, dehydroepiandrosterone sulfate, delta 5-androstenediol, delta 4-androstenedione, testosterone, and dihydrotestosterone. , 1979, The Journal of clinical endocrinology and metabolism.

[25]  P. Ramwell,et al.  Androgen-mediated sensitivity in platelet aggregation. , 1977, The American journal of physiology.

[26]  G. Meschia,et al.  Relationship of the metabolic clearance rate of dehydroisoandrosterone sulfate to placental blood flow: a mathematical model. , 1976, American journal of obstetrics and gynecology.

[27]  N. Cant,et al.  Metabolic Clearance Rate of Dehydroisoandrosterone Sulfate V. Studies of Essential Hypertension Complicating Pregnancy , 1976, Obstetrics and gynecology.

[28]  P. Siiteri,et al.  Study of the metabolic clearance rate of dehydroisoandrosterone sulfate in pregnancy. , 1971, American journal of obstetrics and gynecology.